U.S. Stock News

NasdaqGS:SMTC
NasdaqGS:SMTCSemiconductor

Should Semtech’s (SMTC) New Covenant‑Heavy Credit Facility Reshape Views on Its Capital Flexibility?

In early July 2026, Semtech Corporation entered into a new Credit Agreement establishing a US$360,000,000 revolving credit facility and an uncommitted incremental term loan option, replacing its prior JPMorgan-led facility and extending committed liquidity through July 6, 2031, subject to detailed leverage, coverage, collateral, and covenant conditions. An interesting aspect of this agreement is the leverage-based pricing grid and first-lien security package, which directly link Semtech’s...
NYSE:CVX
NYSE:CVXOil and Gas

Chevron (CVX) Gains On Oil And Power Deal, Is The Stock Still Undervalued?

Renewed tensions between the U.S. and Iran have pushed oil prices higher, putting Chevron (CVX) in focus as investors weigh stronger earnings prospects alongside a new 20-year power supply deal with Microsoft. See our latest analysis for Chevron. Chevron’s share price has been choppy, with a 7.06% decline over the past 30 days and a 6.44% drop over 90 days. However, the year to date share price return of 13.15% and 1 year total shareholder return of 18.34% suggest longer term momentum remains...
NasdaqGS:AMD
NasdaqGS:AMDSemiconductor

AMD (AMD) Stock Looks Fully Priced As Its Five Year Run Stretches On

Advanced Micro Devices stock has surged over the past five years, yet its valuation signals are pulling in different directions, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a premium while market multiples still screen as supportive. Advanced Micro Devices has delivered a very large 5 year return of 549.5%, which means any new buyer is paying in the context of a long, powerful run. Heavy expectations around AI related data center growth can support the current...
NYSE:PFE
NYSE:PFEPharmaceuticals

Pfizer (PFE) Wins FDA Approval For First Platinum Free Bladder Cancer Regimen

FDA approved PADCEV (enfortumab vedotin-ejfv) plus Keytruda (pembrolizumab) for adult patients with muscle-invasive bladder cancer. The regimen is cleared for both neoadjuvant and adjuvant use, regardless of cisplatin eligibility. This is the first platinum-free treatment option for this indication, following results from the Phase 3 EV-304 trial. For investors tracking Pfizer (NYSE:PFE), this approval adds a fresh catalyst to an oncology portfolio that remains a core focus for the company...
NYSE:BAC
NYSE:BACBanks

How Investors May Respond To Bank of America (BAC) Stress Test Win, New Debt Issuance and Q2 Earnings

In recent weeks, Bank of America has passed the Federal Reserve’s 2026 stress tests, redeemed US$2.60 billion of senior notes, and issued multiple new senior unsecured fixed‑income offerings across currencies and maturities. Together with extending large credit facilities to AI firms, exploring a purchase of Fiserv’s debit network, and activating its FIFA World Cup 2026 sponsorship, the bank is sharpening its focus on payments infrastructure, funding flexibility and brand reach across...
NYSE:MA
NYSE:MADiversified Financial

Is Mastercard (MA) Undervalued On Its New AI Payments Push?

Mastercard (MA) is pushing deeper into AI driven payments with its Agent Pay for Machines (AP4M) platform, which connects traditional card networks to stablecoin settlement on public blockchains for autonomous software transactions. See our latest analysis for Mastercard. Against this backdrop of AI driven initiatives, Mastercard’s share price has been mixed, with a 30 day share price return of 7.70% contrasting with a year to date share price decline of 6.46%, while 5 year total shareholder...
NYSE:LEU
NYSE:LEUOil and Gas

Centrus Energy (LEU) Finalized A $1b DOE Contract, Is It Still Below Fair Value?

Centrus Energy (LEU) is back in focus after finalizing a more than US$1b enrichment contract with the U.S. Department of Energy. This move shifts the company toward commercial scale HALEU production. See our latest analysis for Centrus Energy. The contract news has arrived during a rebound phase for Centrus Energy, with a 30 day share price return of 16.67% and a 7 day gain of 5.50%. However, the year to date share price return is still down 37.23% and the 1 year total shareholder return is...
NasdaqGS:WIX
NasdaqGS:WIXIT

How Investors May Respond To Wix.com (WIX) Partnering With Elavon On Unified Commerce For SMBs

Earlier this week, Wix and Elavon, a U.S. Bank subsidiary processing nearly nine billion transactions annually, launched an integrated Elavon Business Solutions and Wix offering that unifies online and in-person sales, payments, bookings, inventory and analytics for small businesses across three tiers: Launch, Grow and Scale. This tiered partnership aims to let small businesses expand without switching platforms as their needs evolve, deepening Wix’s role at the center of unified commerce...
NYSE:SHAK
NYSE:SHAKHospitality

Shake Shack (SHAK) Gains World Cup Buzz As Valuation Questions Return

Fresh optimism around Shake Shack (SHAK) has been triggered by expectations that the 2026 FIFA World Cup could lift foot traffic and sales, and a supportive stance from D.A. Davidson has added to the renewed interest in the stock. See our latest analysis for Shake Shack. At a share price of $58.60, Shake Shack has seen short term momentum return, with a 1 month share price return of 7.56%. However, this follows a much steeper 90 day share price decline of 40.57% and a 1 year total shareholder...
NYSE:UAMY
NYSE:UAMYMetals and Mining

United States Antimony (UAMY) Could Be 51% Undervalued As Expansion Plans Take Shape

United States Antimony (UAMY) has drawn investor attention after recent trading left the stock at a last close of $6.46, with performance mixed between shorter term weakness and longer term gains. See our latest analysis for United States Antimony. Recent trading has been weak for United States Antimony, with the share price return down 2.42% over one day and 13.06% over seven days. This contrasts with a 1-year total shareholder return of 137.50%, which points to a previously strong run that...
NasdaqCM:RZLT
NasdaqCM:RZLTBiotechs

Vivani Stock Puts These Obesity And Diabetes Treatment Stocks On The Radar

The race to reshape obesity and diabetes treatment is moving beyond weekly injections, and Vivani Medical’s long-acting GLP-1 implant has pushed that story into the spotlight. For investors, the question is how this kind of delivery shift might affect companies tied to GLP-1 drugs, devices, and support therapies. This article looks at 3 stocks from our Obesity and Diabetes Treatment Innovation screener that appear positively exposed to the same forces driving interest in Vivani’s semaglutide...
NYSE:BLDR
NYSE:BLDRBuilding

Builders FirstSource (BLDR) Is Down 10.6% After Softer Q1 Amid Housing and Cost Pressures

In late April 2026, Builders FirstSource reported softer first‑quarter results amid weaker housing starts and commodity deflation, while sector-wide pressure intensified as geopolitical tensions pushed oil prices higher, stoking inflation and mortgage rate concerns that weighed on housing-related companies. At the same time, investors are watching how Builders FirstSource’s growing mix of higher-value-added products and services might cushion margins against rising input and freight costs...
NYSE:F
NYSE:FAuto

Ford (F) Appoints BlackRock Veteran To Lead Policy During A Pivotal Auto Period

Ford Motor (NYSE:F) has appointed Matt VanKuiken as Chief Government Affairs Officer. VanKuiken, a former BlackRock executive with prior government experience, will lead Ford's policy strategy and representation. The role includes engagement on issues such as USMCA and emissions standards during a key period for the automotive industry. Ford Motor enters this leadership change with its stock at $14.0 and a return of 24.7% over the past year and 38.8% over the past five years. In the shorter...
NYSE:BE
NYSE:BEElectrical

Bloom Energy (BE) Stock Looks Cheap On Cash Flow Yet Pricey On Sales

Bloom Energy stock has logged an extremely strong three year gain of about 12.9x, yet its valuation signals are split, with a Discounted Cash Flow (DCF) intrinsic value estimate suggesting the shares trade below fair value while traditional market multiples point to an expensive profile. Over the past three years, Bloom Energy has delivered a very large return of about 1,290.6%, so recent buyers are coming in after a substantial re rating. Expectations around Bloom Energy's role in powering...
NYSE:CCS
NYSE:CCSConsumer Durables

Century Communities (CCS) Launches New Arizona And North Carolina Communities Online

Century Communities (NYSE:CCS) has opened new residential communities in Lake Havasu City, Arizona and Wilson, North Carolina. The DL Ranch and Bright Leaf projects expand the company’s presence in two growing housing markets. Both communities feature Century Communities’ online homebuying platform, allowing buyers to complete purchases digitally. Century Communities, trading at $65.04, is adding fresh product in Arizona and North Carolina at a time when investors are watching where...
NYSE:MRK
NYSE:MRKPharmaceuticals

Can Merck (MRK) Be A Bargain If Earnings Look Fair?

Merck stock has delivered an 85.1% total return over the past five years, yet the current checks send a mixed message, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to meaningful upside while the broader valuation score is less conclusive. Over five years, Merck is up 85.1%, which puts recent valuation questions into the context of a strong long term run. Regulatory approvals and late stage pipeline progress can support expectations for future cash flows, while setbacks...
NasdaqGS:CART
NasdaqGS:CARTConsumer Retailing

Maplebear (CART) Looks Fairly Valued Following Its Recent Share Price Run

Maplebear (CART), better known as Instacart, has drawn fresh investor attention after recent trading data highlighted its stock performance over the past month and the past 3 months, prompting closer scrutiny of its business fundamentals. See our latest analysis for Maplebear. At a latest share price of $48.39, Maplebear’s 30-day share price return of 17.42% and 90-day share price return of 23.29% suggest building momentum, while the 1-year total shareholder return of 0.83% points to a...
NYSE:TSN
NYSE:TSNFood

Tyson Foods Stock Faces Fresh Pressure From Arkansas Tariffs

Arkansas import-heavy companies are feeling the sting of tariffs, with importers paying an added $925 million in duties from March 2025 to March 2026. For investors, that kind of cost pressure can reshape which stocks look attractive and which might carry more risk. This article focuses on Tariff Impacted Arkansas Based Companies With Import Exposure and explains how higher import costs, squeezed margins, and potential price increases for customers could affect share prices. Below, you will...
NYSE:LUV
NYSE:LUVAirlines

Is New Klarna Partnership And Air Premia Tie-Up Altering The Investment Case For Southwest (LUV)?

In early July 2026, Klarna Group plc and Southwest Airlines Co. announced a long-term partnership to offer flexible, transparent payment options for flights booked via Southwest’s website and app, while an interline agreement with Korea’s Air Premia opened single-ticket access from South Korea to more than 120 Southwest destinations through Los Angeles, San Francisco, and Honolulu. Together, these partnerships give Southwest deeper reach into East Asian demand and more flexible payment...
NYSE:CWT
NYSE:CWTWater Utilities

Is California Water Service Group (CWT) Fully Valued After A 16% Gain?

California Water Service Group’s stock has gained 15.7% year to date, yet the current checks point to an expensive picture, with both the Dividend Discount Model (DDM) intrinsic value estimate and market multiples indicating the shares trade at a premium. Year to date, California Water Service Group is up 15.7%, which means recent buyers are paying a higher entry price than they would have at the start of the year. The completed acquisition of Palm Mutual Water Company can support long term...
NasdaqGS:RXRX
NasdaqGS:RXRXBiotechs

Recursion Pharmaceuticals (RXRX) Highlights Clinical Progress, Is The Stock Fully Priced?

Recursion Pharmaceuticals (RXRX) is back in focus after its latest earnings materials highlighted encouraging safety data for REC-1245 and strong Phase 2 results for REC-4881, alongside ongoing FDA discussions and fresh buying interest from ARK Investment. See our latest analysis for Recursion Pharmaceuticals. Despite the latest clinical updates and ARK Investment interest, Recursion Pharmaceuticals’ recent momentum has cooled, with the share price down 6.3% over the past week after a 17.1% 1...
NasdaqGS:TENB
NasdaqGS:TENBSoftware

Microsoft Stock Leads 3 AI Software Picks Worth Watching

Artificial intelligence is moving from buzzword to real-world infrastructure, and investors are looking for clear ways to get exposure while bond yields, inflation patterns and energy costs keep shifting across regions. Our AI Stocks screener focuses on companies directly tied to the ChatGPT and AI build out in semiconductors, software, large language models, cloud and broader digital transformation. Instead of trying to track every macro headline, you can use this theme to focus on...
NasdaqGS:FIZZ
NasdaqGS:FIZZBeverage

Should National Beverage’s (FIZZ) Special Dividend Amid Softer Results Require Action From Investors?

National Beverage Corp. reported full-year results for the period ended May 2, 2026, with sales of US$1,180.55 million and net income of US$183.65 million, slightly lower than the prior year, while also declaring a special cash dividend of US$3.25 per share to be paid on or before July 30, 2026. Alongside modest year-over-year declines in sales and earnings per share, the decision to issue a sizable special dividend underscores the company’s focus on returning cash to shareholders. Next,...
NYSE:B
NYSE:BMetals and Mining

Barrick Mining (B) Sets Q2 2026 Earnings Date, Is The Stock Still Cheap?

Barrick Mining (NYSE:B) has scheduled its second quarter 2026 earnings release for August 10, 2026 at 6:00 AM ET, followed by a webcast and analyst Q&A at 11:00 AM ET. See our latest analysis for Barrick Mining. Barrick Mining’s recent share price has eased back, with the stock down 4.0% over the past week and 16.8% year to date, yet its 1 year total shareholder return of 76.8% points to strong longer term momentum. If this earnings update has you thinking more broadly about gold producers,...